We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+14.04%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$1.77B
AUM Growth
+$478M
Cap. Flow
+$459M
Cap. Flow %
25.84%
Top 10 Hldgs %
26.92%
Holding
375
New
143
Increased
47
Reduced
48
Closed
115

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.88%
2 Communication Services 13.06%
3 Technology 7.1%
4 Industrials 6.46%
5 Healthcare 5.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHDN icon
226
CALL
Churchill Downs
CHDN
$5.76B
$587K 0.03%
+13,000
New +$581K
OBSV
227
DELISTED
ObsEva SA Ordinary Shares
OBSV
$582K 0.03%
45,500
-30,100
-40% -$388K
LFCR icon
228
Lifecore Biomedical
LFCR
$164M
$570K 0.03%
46,457
-34,595
-43% -$422K
XLE icon
229
State Street Energy Select Sector SPDR ETF
XLE
$39.2B
$563K 0.03%
17,042
-4,954
-23% -$159K
PENN icon
230
PUT
PENN Entertainment
PENN
$2.75B
$543K 0.03%
+27,000
New +$631K
IVW icon
231
iShares S&P 500 Growth ETF
IVW
$72.7B
$514K 0.03%
11,920
+3,764
+46% +$154K
FBM
232
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$512K 0.03%
52,000
+39,285
+309% +$381K
VIVE
233
DELISTED
VIVEVE MED INC
VIVE
$505K 0.03%
538
+193
+56% +$205K
URA icon
234
Global X Uranium ETF
URA
$5.51B
$500K 0.03%
40,000
UFS
235
DELISTED
DOMTAR CORPORATION (New)
UFS
$494K 0.03%
9,953
-27,491
-73% -$1.31M
VIAB
236
DELISTED
Viacom Inc. Class B
VIAB
$484K 0.03%
+17,253
New +$495K
XRT icon
237
State Street SPDR S&P Retail ETF
XRT
$453M
$473K 0.03%
+10,500
New +$467K
BHVN
238
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$467K 0.03%
9,069
+3,059
+51% +$132K
ACAD icon
239
Acadia Pharmaceuticals
ACAD
$4.55B
$420K 0.02%
+15,644
New +$365K
WLK icon
240
Westlake Corp
WLK
$9.19B
$409K 0.02%
+6,023
New +$436K
PTE
241
DELISTED
PolarityTE, Inc. Common Stock
PTE
$379K 0.02%
1,418
-12,461
-90% -$4.61M
USWSW
242
CALL
DELISTED
U.S. Well Services, Inc. Warrants
USWSW
$362K 0.02%
350,000
AN icon
243
PUT
AutoNation
AN
$7.18B
$357K 0.02%
+10,000
New +$362K
AKRX
244
DELISTED
Akorn Inc
AKRX
$357K 0.02%
101,529
-1,133,280
-92% -$4.35M
SAVE
245
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
$349K 0.02%
+6,600
New +$380K
AMRN
246
Amarin Corp
AMRN
$298M
$347K 0.02%
835
-6,719
-89% -$2.42M
FTCH
247
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$336K 0.02%
+12,494
New +$280K
NEOS
248
DELISTED
Neos Therapeutics, Inc
NEOS
$313K 0.02%
120,000
-546,000
-82% -$1.28M
MNK
249
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$294K 0.02%
+13,509
New +$288K
CRTO icon
250
Criteo S.A. Ordinary Shares
CRTO
$1.1B
$282K 0.02%
+14,059
New +$358K

Similar funds

J. Goldman & Co's Q1 2019 Portfolio in Review

As of Q1 2019, J. Goldman & Co held 375 positions worth $1.77B, up 37% from $1.3B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

J. Goldman & Co deployed $459M of net new capital in Q1 2019, opening 143 new positions and adding to 47 existing holdings. Its largest new stake was Vonage Holdings Corporation: 3,722,294 shares worth $37.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Communication Services and Technology.

On the sell side, the largest reduction was Collegium Pharmaceutical, an estimated $13.3M trimmed.

  • J. Goldman & Co's largest Q1 2019 buy was Vonage Holdings Corporation: 3,722,294 shares worth $37.4M.
  • J. Goldman & Co added most to Walt Disney in Q1 2019, an estimated $84.2M increase.
  • J. Goldman & Co's biggest Q1 2019 reduction was Collegium Pharmaceutical, cutting an estimated $13.3M.
  • J. Goldman & Co fully exited Ralph Lauren in Q1 2019, selling an estimated $37.2M.
  • J. Goldman & Co's ten largest holdings make up 27% of its $1.77B portfolio in Q1 2019.
  • J. Goldman & Co opened 143 new positions and closed 115 in Q1 2019.
  • J. Goldman & Co's portfolio value rose 37% quarter-over-quarter to $1.77B.

Based on J. Goldman & Co's 13F filing for Q1 2019, filed 14 May 2019.